EVENT | RAPS Euro Convergence
We are thrilled to announce that the Asphalion team will be attending RAPS Euro Convergence 2025, taking
April 22, 2025
We are thrilled to announce that the Asphalion team will be attending RAPS Euro Convergence 2025, taking
As of April 14th, 2025, the new FDA ESG NextGen submission portal has officially launched!!
We are pleased to announce that ASPHALION will participate in the third edition of Connection Day, organised
Join Asphalion and many more Life Science industry experts at EXTEDO’s eRA conference next month in Frankfurt!
Navigating the regulatory pathways for medical device approval in the United States can be complex. Two of the key components in this journey include the Pre-Submission process and 510(k) clearance, both of which engage with the Food and Drug Administration (FDA) to ensure that new or modified devices meet safety standards while supporting innovation and technological progress.
Asphalion fue galardonada con el Premio AEFI como empresa de menos de 250 trabajadores más comprometida con la formación de sus empleados por tercer año consecutivo
Good news at Asphalion! We are thrilled to announce that Carmen Ulla has been appointed Operations Director
On April 3rd, Asphalion’s Montse Domingo participated in the first working session on the upcoming European Research
Search or filter
Services
SDGs
As a company committed to sustainability, we follow the UN’s 2030 Agenda and its Sustainable Development Goals.
Memberships & PartnershipS
Quality Management System
Innovative SME
SDGs
As a company committed to sustainability, we follow the UN’s 2030 Agenda and its Sustainable Development Goals.
© Asphalion
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
